Unopposed Production of Granulocyte-Macrophage Colony-Stimulating Factor by Tumors Inhibits CD8+ T Cell Responses by Dysregulating Antigen-Presenting Cell Maturation
Open Access
- 15 May 1999
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 162 (10) , 5728-5737
- https://doi.org/10.4049/jimmunol.162.10.5728
Abstract
Tumor cells gene-modified to produce GM-CSF potently stimulate antitumor immune responses, in part, by causing the growth and differentiation of dendritic cells (DC). However, GM-CSF-modified tumor cells must be γ-irradiated or they will grow progressively, killing the host. We observed that 23 of 75 (31%) human tumor lines and two commonly used mouse tumor lines spontaneously produced GM-CSF. In mice, chronic GM-CSF production by tumors suppressed Ag-specific CD8+ T cell responses. Interestingly, an inhibitory population of adherent CD11b(Mac-1)/Gr-1 double-positive cells caused the observed impairment of CD8+ T cell function upon direct cell-to-cell contact. The inhibitory cells were positive for some markers associated with Ag presenting cells, like F4/80, but were negative for markers associated with fully mature DC like DEC205, B7.2, and MHC class II. We have previously reported that a similar or identical population of inhibitory “immature” APC was elicited after immunization with powerful recombinant immunogens. We show here that these inhibitory cells can be elicited by the administration of recombinant GM-CSF alone, and, furthermore, that they can be differentiated ex vivo into “mature” APC by the addition of IL-4 and GM-CSF. Thus, tumors may be able to escape from immune detection by producing “unopposed” GM-CSF, thereby disrupting the balance of cytokines needed for the maturation of fully functional DC. Further, CD11b/Gr-1 double-positive cells may function as “inhibitory” APC under the influence of GM-CSF alone.Keywords
This publication has 64 references indexed in Scilit:
- Enhanced Tumor Protection by Granulocyte-Macrophage Colony-Stimulating Factor Expression at the Site of an Allogeneic VaccineHuman Gene Therapy, 1998
- The host—tumor immune conflict: from immunosuppression to resistance and destructionImmunology Today, 1997
- Route of Immunization and the Therapeutic Impact of Recombinant Anticancer VaccinesJNCI Journal of the National Cancer Institute, 1997
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996
- GM-CSF secretion in primary cultures of normal and cancerous human renal cellsKidney International, 1996
- A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis.The Journal of Experimental Medicine, 1996
- Production of IL‐10 by melanoma cells: Examination of its role in immunosuppression mediated by melanomaInternational Journal of Cancer, 1994
- Identification of human cancers deficient in antigen processing.The Journal of Experimental Medicine, 1993
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow TransplantationNew England Journal of Medicine, 1988
- Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells.The Journal of Experimental Medicine, 1987